Growth Metrics

Cryo Cell International (CCEL) Cash & Current Investments (2016 - 2026)

Cryo Cell International's Cash & Current Investments history spans 17 years, with the latest figure at $2.9 million for Q1 2026.

  • Quarterly results put Cash & Current Investments at $2.9 million for Q1 2026, down 16.65% from a year ago — trailing twelve months through Feb 2026 was $2.9 million (down 16.65% YoY), and the annual figure for FY2025 was $3.3 million, down 5.72%.
  • Cash & Current Investments for Q1 2026 was $2.9 million at Cryo Cell International, down from $3.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $4.4 million in Q2 2025 to a low of $979593.0 in Q1 2024.
  • The 5-year median for Cash & Current Investments is $2.6 million (2022), against an average of $2.5 million.
  • The sharpest move saw Cash & Current Investments crashed 79.35% in 2022, then skyrocketed 256.66% in 2024.
  • Year by year, Cash & Current Investments stood at $1.7 million in 2022, then plummeted by 43.06% to $980250.0 in 2023, then skyrocketed by 256.66% to $3.5 million in 2024, then dropped by 5.72% to $3.3 million in 2025, then decreased by 12.01% to $2.9 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $2.9 million, $3.3 million, and $3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.